Intervertebral disc regeneration

Intervertebral disc regeneration is a complex biological process and therapeutic objective aimed at restoring the structural and functional integrity of a degenerated intervertebral disc (IVD). This process is not a single molecular target but rather a multifaceted clinical goal involving the stimulation of anabolic activities, such as the production of aggrecan and type II collagen, and the inhibition of catabolic enzymes like matrix metalloproteinases (MMPs) and ADAMTS within the nucleus pulposus and annulus fibrosus (PubMed: 25684360). Intervertebral disc degeneration (IDD) is a primary cause of chronic low back pain and is characterized by the loss of proteoglycan content and cellularity (NIH: PMC7402012). Therapeutic strategies currently under investigation for disc regeneration include the administration of growth factors (e.g., BMP-7, TGF-beta), the transplantation of mesenchymal stem cells (MSCs), and the application of gene therapies or biomimetic scaffolds (Nature Reviews Rheumatology: 10.1038/nrrheum.2017.13). While various drugs and biologics are being developed to facilitate this process, 'Intervertebral disc regeneration' describes the desired physiological outcome rather than a specific receptor or enzyme that can be directly modulated. Biotech analysts should identify specific molecular targets within this pathway, such as inflammatory cytokines or specific signaling receptors, for precise drug development.

Other names

IVD regenerationDisc repairRegeneration of the intervertebral disc

Not applicable as this is a physiological process/therapeutic goal rather than a single molecular target.